Table 2. Risk estimates for p53 haplotypes in male OSCC patients and control subjects.

^aOther OSCC patients: including oropharynx and hypopharynx cancer patients.

^bW: common allele (without replicative 16 bp); M : rare allele (with replicative 16 bp).